CN111358832A - 用于改善认知健康和认知功能的植物提取物 - Google Patents

用于改善认知健康和认知功能的植物提取物 Download PDF

Info

Publication number
CN111358832A
CN111358832A CN202010406999.5A CN202010406999A CN111358832A CN 111358832 A CN111358832 A CN 111358832A CN 202010406999 A CN202010406999 A CN 202010406999A CN 111358832 A CN111358832 A CN 111358832A
Authority
CN
China
Prior art keywords
memory
learning
samp8
mice
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010406999.5A
Other languages
English (en)
Chinese (zh)
Inventor
M·切迪亚
K·赫林格尔
B·刘易斯
H·冯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kemin Industries Inc
Original Assignee
Kemin Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kemin Industries Inc filed Critical Kemin Industries Inc
Publication of CN111358832A publication Critical patent/CN111358832A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
CN202010406999.5A 2012-08-09 2013-08-09 用于改善认知健康和认知功能的植物提取物 Pending CN111358832A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261681414P 2012-08-09 2012-08-09
US61/681,414 2012-08-09
CN201380051858.4A CN104684562A (zh) 2012-08-09 2013-08-09 用于改善认知健康和认知功能的植物提取物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201380051858.4A Division CN104684562A (zh) 2012-08-09 2013-08-09 用于改善认知健康和认知功能的植物提取物

Publications (1)

Publication Number Publication Date
CN111358832A true CN111358832A (zh) 2020-07-03

Family

ID=50066333

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202010406999.5A Pending CN111358832A (zh) 2012-08-09 2013-08-09 用于改善认知健康和认知功能的植物提取物
CN201380051858.4A Pending CN104684562A (zh) 2012-08-09 2013-08-09 用于改善认知健康和认知功能的植物提取物

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201380051858.4A Pending CN104684562A (zh) 2012-08-09 2013-08-09 用于改善认知健康和认知功能的植物提取物

Country Status (11)

Country Link
US (2) US20140044813A1 (cg-RX-API-DMAC7.html)
EP (1) EP2882443B1 (cg-RX-API-DMAC7.html)
JP (4) JP2015524484A (cg-RX-API-DMAC7.html)
KR (1) KR101947352B1 (cg-RX-API-DMAC7.html)
CN (2) CN111358832A (cg-RX-API-DMAC7.html)
AU (1) AU2013299491B2 (cg-RX-API-DMAC7.html)
BR (1) BR112015002739A2 (cg-RX-API-DMAC7.html)
CA (1) CA2880708C (cg-RX-API-DMAC7.html)
ES (1) ES2715005T3 (cg-RX-API-DMAC7.html)
PL (1) PL2882443T3 (cg-RX-API-DMAC7.html)
WO (1) WO2014026081A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140044813A1 (en) * 2012-08-09 2014-02-13 Kemin Industries, Inc. Plant Extracts for Improving Cognitive Health and Function
KR20160113277A (ko) * 2014-01-30 2016-09-28 케민 인더스트리즈, 인코포레이티드 인지 기능을 개선시키기 위한 식물 추출물
CA2961378A1 (en) * 2014-09-15 2016-03-24 Kemin Industries, Inc. Plant extracts for improving cognitive function
CA2963817A1 (en) * 2014-10-08 2016-04-14 Abbott Laboratories Nutritional compositions comprising an oxidizable component and water-soluble plant extract
JP2020508962A (ja) * 2016-11-11 2020-03-26 ケミン、インダストリーズ、インコーポレーテッドKemin Industries, Inc. 神経新生の促進を通して脳の健康を改善するための植物抽出物の使用
CN106727915B (zh) * 2017-01-18 2020-03-31 云南德彩堂生物医药科技有限公司 一种稳定高效提高记忆的组合物及其制备方法和应用
BR112020008727A2 (pt) * 2017-10-30 2020-10-20 Neuropore Therapies, Inc. fenil sulfonil fenil triazol tionas substituídas e usos destas
CN109602759B (zh) * 2019-01-17 2020-10-09 广西医科大学 罗汉松实多糖的用途
KR102421772B1 (ko) * 2019-05-21 2022-07-18 건국대학교 글로컬산학협력단 클로로필 및 로즈마린산을 포함하는 미세먼지에 의해 유발된 신경염증 또는 신경 퇴행성 질환의 예방 또는 치료용 조성물
CN110463846A (zh) * 2019-07-30 2019-11-19 河南科技学院 留兰香提取物在制备抗宠物衰老药物或宠物食品中的应用
JP7330630B2 (ja) * 2019-11-20 2023-08-22 株式会社ニップン ロスマリン酸及びカルノシン酸を有効成分とする神経突起伸長誘導作用を有する組成物
JP2022104122A (ja) * 2020-12-28 2022-07-08 株式会社ニップン オキシトシン関連シグナル活性化剤
US20240139272A1 (en) * 2022-10-27 2024-05-02 Kemin Industries, Inc. Use of a spearmint extract for retina neurotrophism
JP2024122605A (ja) * 2023-02-28 2024-09-09 株式会社ニップン オリゴデンドロサイト分化促進剤

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391344B2 (en) * 1999-12-02 2002-05-21 Nagase & Company, Ltd. Method of promoting synthesis of nerve growth factor
JP2006199666A (ja) * 2005-01-24 2006-08-03 Nagase & Co Ltd 健忘症の予防・治療剤
WO2008090474A2 (en) * 2007-01-24 2008-07-31 University Of Guelph Production of rosmarinic acid from spearmint and uses thereof
JP2011256118A (ja) * 2010-06-07 2011-12-22 Kao Corp Il−8及びgm−csf発現抑制剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1219509C (zh) * 1998-05-16 2005-09-21 财团法人牧岩生命工学研究所 迷迭香酸及其衍生物用于制备免疫抑制剂药物的用途
WO2007047978A2 (en) * 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
EP1930019A1 (en) * 2006-11-24 2008-06-11 DSMIP Assets B.V. Rosemary extracts, dietary and pharmaceutical compositions containing them and their uses
EP1925213A1 (en) * 2006-11-24 2008-05-28 DSMIP Assets B.V. Dietary and pharmaceutical compositions comprising a sage extract comprising a mixture of tricyclic diterpenes and their derivatives and their uses
US7972633B2 (en) * 2007-02-07 2011-07-05 Applied Cognitive Sciences, LLC Nutritional supplements for healthy memory and mental function
DK2060192T3 (en) * 2007-10-17 2016-02-22 Wild Gmbh & Co Kg Rudolf Composition comprising lemon balm extracts
US9950019B2 (en) * 2009-06-12 2018-04-24 Generex Pharmaceuticals, Inc. Compositions and methods for the prevention and treatment of brain diseases and conditions
CN101773488A (zh) * 2010-02-10 2010-07-14 青岛大学 一种基于迷迭香酸的药物及其在治疗帕金森病中的应用
US20140044813A1 (en) * 2012-08-09 2014-02-13 Kemin Industries, Inc. Plant Extracts for Improving Cognitive Health and Function

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391344B2 (en) * 1999-12-02 2002-05-21 Nagase & Company, Ltd. Method of promoting synthesis of nerve growth factor
JP2006199666A (ja) * 2005-01-24 2006-08-03 Nagase & Co Ltd 健忘症の予防・治療剤
WO2008090474A2 (en) * 2007-01-24 2008-07-31 University Of Guelph Production of rosmarinic acid from spearmint and uses thereof
JP2011256118A (ja) * 2010-06-07 2011-12-22 Kao Corp Il−8及びgm−csf発現抑制剤

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DONG HYUN PARK等: "Subchronic administration of rosmarinic acid, a natural prolyl oligopeptidase inhibitor, enhances cognitive performances", 《FITOTERAPIA》 *
TURSUN ALKAM等: "A natural scavenger of peroxynitrites, rosmarinic acid, protects against impairment of memory induced by Aβ25–35", 《BEHAVIOURAL BRAIN RESEARCH》 *
无: "科学家发现能有效保护脑神经细胞的植物", 《生物学通报》 *

Also Published As

Publication number Publication date
US20140044813A1 (en) 2014-02-13
EP2882443B1 (en) 2019-01-16
JP2015524484A (ja) 2015-08-24
AU2013299491B2 (en) 2018-03-15
JP2025029029A (ja) 2025-03-05
JP2021066735A (ja) 2021-04-30
ES2715005T3 (es) 2019-05-31
EP2882443A1 (en) 2015-06-17
JP2023027232A (ja) 2023-03-01
KR20150041654A (ko) 2015-04-16
KR101947352B1 (ko) 2019-02-12
CA2880708C (en) 2023-09-26
AU2013299491A1 (en) 2015-02-12
BR112015002739A2 (pt) 2017-07-04
US20250009703A1 (en) 2025-01-09
WO2014026081A1 (en) 2014-02-13
CN104684562A (zh) 2015-06-03
PL2882443T3 (pl) 2019-06-28
EP2882443A4 (en) 2016-01-06
CA2880708A1 (en) 2014-02-13

Similar Documents

Publication Publication Date Title
US20250009703A1 (en) Plant extracts for improving cognitive health and function
Maczurek et al. Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease
Chaudhari et al. Neurocognitive effect of nootropic drug Brahmi (Bacopa monnieri) in Alzheimer's disease
Farr et al. Effect of botanical extracts containing carnosic acid or rosmarinic acid on learning and memory in SAMP8 mice
Hang et al. Nutraceuticals in Parkinson’s disease
Reza-Zaldívar et al. Comprehensive review of nutraceuticals against cognitive decline associated with Alzheimer’s disease
Lin et al. Carnosic acid protects SH-SY5Y cells against 6-hydroxydopamine-induced cell death through upregulation of parkin pathway
US20180311209A1 (en) Dosing regimens of pkc activators
Cho et al. Neuroprotective effects of Actinidia eriantha cv. Bidan kiwifruit on amyloid beta-induced neuronal damages in PC-12 cells and ICR mice
Meng et al. Comparative analyses of DHA‐phosphatidylcholine forage and liposomes on alzheimer's disease in SAMP8 mice
US20200093929A1 (en) Pharmaceutical composition for the prevention and treatment of memory and cognitive deficits related to ageing
Farooqui Beneficial effects of ginkgo biloba in neurological disorders
Boldrini et al. Potential use of modulators of oxidative stress as add-on therapy in patients with anxiety disorders
Mehta et al. Exploring nordihydroguaretic acid (NDGA) as a plausible neurotherapeutic in the experimental paradigm of autism spectrum disorders targeting nitric oxide pathway
Gutierrez et al. Prevention of cognitive decline
Gonçalves et al. Neuroprotective Effects of Olive Oil: A Comprehensive Review of Antioxidant Properties. Antioxidants 2024, 13, 762
Yan et al. Dietary beta-hydroxybutyrate is superior to a ketogenic diet to improve behavior and abnormal myelination in a mouse model of NMDA receptor deficiency
Maher Grapes and brain health
Ghibhela et al. Chapter-3 Brahmi: A Memory Booster Medicinal Herb
Marques Role of nutrition in adult neurogenesis
Gonçalves et al. Neuroprotective Effects of Olive Oil
Boronat Rigol et al. Olive oil phenolic compounds' activity against age-associated cognitive decline: clinical and experimental evidence
Zhao Tea Polyphenols and Alzheimer’s
Tort Neuroprotective Effect of Olive Oil Polyphenols in Alzheimer’s Disease
Andrade Retarding brain ageing and cognitive decline

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination